,

Issues in Clinical Epileptology: A View from the Bench

Specificaties
Gebonden, 339 blz. | Engels
Springer Netherlands | 2014e druk, 2014
ISBN13: 9789401789134
Rubricering
Springer Netherlands 2014e druk, 2014 9789401789134
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

This book is dedicated to Dr. Philip A. Schwartzkroin. The book has a novel format because it is not intended to be a set of reviews. Instead, it is an effort to explore important topics in the epilepsy research field. Because articles are written by leaders in the field who have years of experience and individuals with diverse expertise, articles are likely to have a long-lasting impact and be relevant for both epileptologists and neuroscientists. Authors address topics that are important, unresolved questions in the field of epilepsy research, drawing on available data from both the bench and the clinic to support their points. A given topic is addressed by one or more authors, each writing from his/her own unique perspective. For all of the individuals who have been trained or worked with Philip Schwartzkroin in the past and/or have appreciated his contributions to the epilepsy field, this volume is an excellent way to celebrate his achievements and look to the ways they have moved the field forward and continue to stimulate its growth.

Specificaties

ISBN13:9789401789134
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:339
Uitgever:Springer Netherlands
Druk:2014

Inhoudsopgave

<p>Preface<br>Foreword Jerome Engel, Marc A. Dichter </p><p>Part I  Seizures, epileptiform activities and regional localization </p><p>1 How can we identify ictal and interictal abnormal activity? Robert Fisher, Helen Scharfman, Marco de Curtis</p><p>2 How can we translate “epileptiform” activity in vitro into something that is clinically relevant? Uwe Heinemann, Kevin Staley </p><p>3 What is the importance of abnormal “background” activity in seizure generation? Richard Staba, Gregory Worrell</p><p>4 What is a seizure focus? J. Victor Nadler, Dennis Spencer</p><p>5 What is a seizure network? Very fast oscillations at the interface between normal and epileptic brain Roger Traub, Mark  Cunningham, Miles Whittington </p><p></p><p>6 What is a seizure network? Long-range network consequences of focal seizures  Hal Blumenfeld </p><p>7 Is there any such thing as “generalized” epilepsy?  Gilles van Luijtelaar, Charles Behr, Massimo Avoli </p><p>Part II Synaptic plasticity </p><p>8 Are there really “epileptogenic” mechanisms or only corruptions of “normal” plasticity? Giuliano Avanzini, Patrick Forcelli, Karen Gale</p><p>9 When and how do seizures kill neurons - and is cell death relevant to epileptogenesis? Raymond Dingledine, Nicholas Varvek,  F. Edward Dudek </p><p>10 How is homeostatic plasticity important in epilepsy? John Swann, Jong Rho  </p><p>11 Is plasticity of GABA ergic mechanisms relevant to epileptogenesis? Helen Scharfman, Amy Brooks-Kayal </p><p>12 Do structural changes in GABA neurons give rise to the epileptic state?  Carolyn Houser</p><p>13 Does mossy fiber sprouting give rise to the epileptic state?  Paul Buckmaster </p><p>14 Does brain inflammation mediate pathological outcomes in epilepsy? Annamaria Vezzani, Karen Wilcox </p><p>15 Are changes in synaptic function that underlie hyperexcitability responsible for seizure activity? John Jefferys </p><p>16 Does epilepsy cause a reversion to immature function? Aristea Galanopoulou, Solomon Moshe</p><p>17 Are alterations in transmitter receptor and ion channel expression responsible for the epilepsies? Kim Powell, Katarzyna Lukasiuk,<sup> </sup>Terence O’Brien,<sup> </sup>Asla Pitkänen</p><p> Part III Models and methods</p><p>18 How do we assess the clinical relevance of models of mesial temporal lobe epilepsy? - Stephen Harward, James McNamara</p><p> </p><p>19 How do we make models that are useful in understanding partial epilepsies? - David Prince</p><p><p>20 What non-neuronal mechanisms should be studied to understand epileptic seizures? Damir Janigro, Matthew Walker </p><p>21 What epilepsy comorbidities are important to model in the laboratory? Clinical perspectives Simon Shorvon</p><p>22.Understanding epilepsy comorbidities: how can animal models help?  Carl Stafstrom </p><p>23 What new modeling approaches will help us identify promising drug treatments? Scott Baraban, Wolfgang Löscher </p><p>24 What are the arguments for and against rational therapy for epilepsy? Melissa Barker-Haliski, Graeme Sills, H. Steve White </p><p>25 How can advances in epilepsy genetics lead to better treatments and cures? Renzo Guerrini, Jeffrey Noebels</p><p>26 How might novel technologies such as optogenetics lead to better treatments in epilepsy? Esther Krook-Magnuson, Marco Ledri, Ivan Soltesz, Merab Kokaia.</p><p>

Rubrieken

Populaire producten

    Personen

      Trefwoorden

        Issues in Clinical Epileptology: A View from the Bench